SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052823
Filing Date
2020-11-10
Accepted
2020-11-10 12:19:17
Documents
44
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lsacu-10q_20200930.htm 10-Q 538519
2 EX-31.1 lsacu-ex311_9.htm EX-31.1 20875
3 EX-31.2 lsacu-ex312_8.htm EX-31.2 20449
4 EX-32.1 lsacu-ex321_7.htm EX-32.1 8293
5 EX-32.2 lsacu-ex322_6.htm EX-32.2 8249
  Complete submission text file 0001564590-20-052823.txt   2417966

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lsacu-20200930.xml EX-101.INS 248627
7 XBRL TAXONOMY EXTENSION SCHEMA lsacu-20200930.xsd EX-101.SCH 36047
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lsacu-20200930_cal.xml EX-101.CAL 13919
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lsacu-20200930_def.xml EX-101.DEF 127995
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lsacu-20200930_lab.xml EX-101.LAB 247309
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lsacu-20200930_pre.xml EX-101.PRE 191603
Mailing Address 250 W 55TH ST #3401 NEW YORK NY 10019
Business Address 250 W 55TH ST #3401 NEW YORK NY 10019 646-889-1200
LifeSci Acquisition Corp. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39244 | Film No.: 201300287
SIC: 2834 Pharmaceutical Preparations